Zubair Khalid

Virologist/Molecular Biologist | Veterinarian | Bioinformatician

Conventional & Molecular Virology • Vaccine Development • Computational Biology

Dr. Zubair Khalid is a veterinarian and virologist specializing in conventional and molecular virology, vaccine development, and computational biology. Dedicated to advancing animal health through innovative research and multi-omics approaches.

Dr. Zubair Khalid - Veterinarian, Virologist, and Vaccine Development Researcher specializing in Computational Biology, Multi-omics, Animal Health, and Infectious Disease Research

Category: Guides

Illumina Personal Genome Sequencing: A Practical Guide

Illumina personal genome sequencing refers to the use of Illumina short read sequencing technology to determine the complete DNA sequence of an individual's genome. This guide is for researchers, clinicians, and informed consumers who want to understand the core concepts, practical decision points, workflow steps, quality checks, common pitfalls, and interpretative limits of personal genome sequencing on Illumina platforms. You will find a source bounded framework that draws on authoritative training resources and peer reviewed studies NCBI Bookshelf. If you are planning a personal genome project or interpreting results from a direct to consumer test that uses Illumina sequencing, this guide will help you navigate the process critically.

The technology relies on sequencing by synthesis, where fluorescently labeled nucleotides are added to a growing DNA strand and imaged. A single run can produce billions of short reads (typically 150 base pairs). These reads are then aligned to a reference genome and variants are called. While the chemistry is mature, the bioinformatics pipeline and the interpretation of results require careful attention EMBL EBI Training.

At a Glance

Aspect Detail
Platform Illumina NovaSeq, HiSeq, MiSeq (personal genome typically done on high throughput instruments)
Read length 100 150 bp paired end
Coverage depth 30x 40x for whole genome sequencing (WGS)
Primary output FASTQ files then aligned BAM then variant VCF
Typical turnaround 1 3 weeks after sample receipt
Cost per genome (2025) USD 600 1,000 (reagent and sequencing)
Key databases NCBI Sequence Read Archive for raw data NCBI SRA
Main applications Rare disease diagnosis, pharmacogenomics, ancestry, polygenic risk scores

Core Concepts

Illumina sequencing relies on clonal amplification of DNA fragments on a flow cell. Each cluster produces a signal that is read by a camera. The base calls have an associated quality score (Phred score). For personal genomes, the standard is paired end sequencing, which gives two reads from each fragment, improving alignment accuracy.

The analysis pipeline has three main stages: primary analysis (base calling), secondary analysis (alignment and variant calling), and tertiary analysis (annotation and interpretation). Open source tools are widely available, and workflows are documented by the Galaxy Training Network Galaxy Training Network. The Bioconductor project provides R packages for downstream statistical analysis Bioconductor.

Personal genome sequencing can detect single nucleotide variants (SNVs), small insertions and deletions (indels), and copy number variants (CNVs) when depth and coverage allow. Structural variants and repetitive regions are harder to call. The raw data should always be deposited in a public repository such as the NCBI Sequence Read Archive NCBI SRA to enable reproducibility.

Decision Points

Before sequencing a personal genome, you need to consider several factors:

1. Library preparation method. PCR free libraries reduce bias but require more input DNA. PCR based libraries are cheaper but can introduce duplicates and GC bias.

2. Coverage depth. For reliable variant calling in the human genome, 30x is the minimum. Higher depth (60x) improves sensitivity for somatic variants but costs more.

3. Read length. Longer reads (150 bp) improve alignment in repetitive regions. Very short reads (50 bp) are not recommended for personal genomes.

4. Paired end vs single end. Always choose paired end for personal genomes. It provides information about fragment size and improves detection of indels and structural variants.

5. Bioinformatics expertise. You need a robust pipeline. Cloud based solutions (e.g., Illumina BaseSpace, DNAnexus) reduce local compute requirements but have data privacy implications.

6. Consent and data sharing. Personal genome data contains sensitive information. Decide whether to share raw data publicly (e.g., in the SRA) and how to handle incidental findings.

7. Validation. Variants of clinical significance should be validated by Sanger sequencing or an orthogonal method.

Workflow Steps

A practical personal genome sequencing project follows these steps:

Step 1: Sample collection and DNA extraction. Use a high quality DNA sample (blood or saliva). Quantify with fluorometry (Qubit) and check integrity by gel electrophoresis.

Step 2: Library preparation. Fragmentation (enzymatic or mechanical), end repair, A tailing, adapter ligation, and PCR (if used). Size select for 300 500 bp inserts.

Step 3: Sequencing on Illumina instrument. Load the library onto the flow cell at the appropriate concentration. Run a paired end 150 bp cycle.

Step 4: Base calling and demultiplexing. The instrument software (RTA) produces FASTQ files. Use bcl2fastq to convert and assign reads to samples.

Step 5: Quality control. Run FastQC on raw reads. Check per base sequence quality, GC content, adapter contamination, and duplication levels. Trim adapters with Cutadapt or Trimmomatic if needed.

Step 6: Alignment. Use BWA MEM to align reads to the reference genome (GRCh38). Output a SAM file, then convert to sorted BAM with SAMtools.

Step 7: Duplicate marking. Use Picard MarkDuplicates to flag PCR duplicates. Do not remove duplicates for clinical pipelines where detection of low frequency variants matters.

Step 8: Indel realignment and base quality score recalibration. Use GATK (Genome Analysis Toolkit) for these steps. They reduce false positives around indels.

Step 9: Variant calling. Use GATK HaplotypeCaller for SNVs and indels. For CNVs, consider freec or CNVnator.

Step 10: Variant filtering. Apply hard filters or use VQSR (Variant Quality Score Recalibration) if you have a large enough dataset.

Step 11: Annotation. Use ANNOVAR, SnpEff, or VEP to add gene, frequency, and functional impact information.

Step 12: Interpretation. Filter for rare, protein altering variants. Compare with databases like ClinVar. For polygenic risk scores, use sum of risk allele weights. For example, a recent study integrated DNA methylation biomarkers and artificial intelligence for breast cancer risk prediction Integrating DNA methylation biomarkers.

Step 13: Reporting. Generate a summary of medically actionable variants, pharmacogenomic findings, and carrier status. Provide raw VCF to the individual upon request.

Quality Checks

Check 1: Coverage distribution. The genome should have >90% of bases covered at 20x. Low coverage regions indicate GC bias or mapping issues.

Check 2: Transition transversion ratio (Ti/Tv). For whole genome, Ti/Tv should be around 2.0 2.1. Lower values suggest sequencing errors.

Check 3: Genotype concordance. If you have SNP array data, compare genotypes for the same positions. Concordance should exceed 99%.

Check 4: Contamination estimation. Use verifyBamID to check for sample mix up or cross contamination.

Check 5: Read depth uniformity. The coefficient of variation of coverage across 100 kb bins should be low. High variability indicates technical problems.

Common Mistakes

Mistake 1: Skipping QC on raw data. Poor quality reads degrade alignment and variant calling. Always run FastQC before trimming.

Mistake 2: Using default cutoffs without understanding. For example, applying a minimum allele frequency filter of 0.01 may remove true rare variants. Adjust based on population.

Mistake 3: Overinterpreting variants in low complexity regions. Homopolymer runs and segmental duplications cause false positives. Check with IGV.

Mistake 4: Ignoring the impact of GC bias. Libraries with high GC content will have uneven coverage. Use PCR free protocols for clinical grade genomes.

Mistake 5: Not validating clinically relevant findings. Sanger sequencing or an orthogonal method should confirm any variant used for diagnosis.

Mistake 6: Relying solely on automated annotation. Tools like SnpEff may miss regulatory variants. Use manual review by a certified geneticist.

Mistake 7: Failing to account for population specific allele frequencies. A variant that is rare in European populations may be common in African populations. Use the appropriate reference panel.

Limits of Interpretation

Personal genome sequencing from Illumina has inherent limitations:

1. Short reads cannot resolve all regions. Repetitive elements, centromeres, telomeres, and segmental duplications are poorly covered. Long read sequencing is required for those.

2. Phasing is limited. Short reads rarely span two heterozygous variants that are far apart. This makes it difficult to determine haplotypes without family data or statistical phasing.

3. Copyright variant detection is incomplete. Small CNVs and structural variants are missed at standard coverage. Algorithms exist but have high false discovery rates.

4. Functional impact predictions are uncertain. Tools like SIFT and PolyPhen give computational scores, but clinical validity requires functional assays and population evidence.

5. Incidental findings are ethically complex. Guidelines from ACMG recommend reporting 59 genes for actionable variants. However, many people may not want to know about certain risks.

6. Polygenic risk scores have limited predictive value in non European populations. A recent study on Chinese adults combined polygenic risk scores with traditional risk factors for type 2 diabetes risk assessment Polygenic risk score. Such models often do not generalize across ancestries.

7. Tumor sequencing applications require matched normal samples. If using personal genome sequencing for cancer, compare with a germline sample. RNA Seq and explainable AI can aid pathologists, but the interpretation is complex RNA Seq and XAI.

8. Microbial DNA can contaminate human genome sequencing. For example, studies on Lactobacillus paragasseri use dedicated protocols Lactobacillus sequencing. If you see unexpected reads, check for contamination.

9. HLA typing from short reads is challenging. A new allele HLA C*14:167 was identified with a non synonymous mutation, but such discoveries require validation HLA novel allele. Short read based HLA typing is often inaccurate.

**10. Genomic differentiation studies, such as in Tectarius striatus, rely on microsatellite resources, not WGS Genetic differentiation. Personal genome sequencing is not suitable for all research questions.

Frequently Asked Questions

Q: How much DNA do I need for Illumina personal genome sequencing?
A: PCR free libraries require 1 2 micrograms of high molecular weight DNA. PCR based libraries can work with as little as 100 nanograms.

Q: Can I get my raw genome data file?
A: Yes. Most sequencing providers will give you FASTQ, BAM, and VCF files. You can also upload to public archives like the NCBI Sequence Read Archive NCBI SRA.

Q: What does 30x coverage mean?
A: It means that, on average, every nucleotide in the genome is sequenced 30 times. Higher coverage increases confidence in variant calls, especially for heterozygous positions.

Q: How long does it take to analyze a personal genome?
A: The computational analysis can take 24 48 hours on a high performance cluster. Cloud platforms can reduce wall time to a few hours.

References and Further Reading

Related Articles